Morgan Stanley Reiterates Overweight on Eli Lilly (LLY), Cites Growth Potential of New Platform.
Share this article
Corporate
Score 65
Bullish
Morgan Stanley Reiterates Overweight on Eli Lilly (LLY), Cites Growth Potential of New Platform
Mar 24, 2026 11:27 UTC
LLY, XLV, IHF
Medium term
Related Articles
Score 25
Grown Alchemist CEO Steps Down, Is Launching Wellness Brand
Mar 24, 13:57
Score 65
Bearish
Estée Lauder shares drop after confirming Puig deal talks
Mar 24, 13:56
Score 65
Bullish
Cardinal Health (CAH) Surged Following Improved Specialty Mix in Pharma
Mar 24, 13:37
Score 45
Bullish
Brown Advisory Mid-Cap Growth Strategy Bets on Medline (MDLN) in IPO
Mar 24, 13:34
Stay Ahead of the Markets
Join thousands of traders using AI-powered market intelligence. Get personalized insights, real-time alerts, and advanced analysis tools.